On today's episode of Bloomberg Businessweek Daily, Carol Massar and Alexis Christoforous discuss today's market action as stocks waver near record highs and bonds decline ahead of next week's Fed decision. Bloomberg's Stuart Paul and Ira Jersey join the show to break it down. Plus, Compass Pathways CEO Kabir Nath talks possible FDA approval for the company's psilocybin depression drug and the path to commercial viability, and Weill Cornell Medicine Women's Heart Program Director Dr. Nupoor